TET2 and acute lymphoblastic leukemia: Indeed, 5-aza treatment resulted in robust and stable re-expression of TET2 in two of three TET2-silenced T-ALL cell lines (LOUCY and DND-41) even after removal of 5-aza, supporting a role for DNA methylation in TET2 suppression.